Approval · Notice of Compliance 7552 · 2005
SOMAVERT: Notice of Compliance 7552
Issued October 17, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7552
- Date
- October 17, 2005
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Growth hormone receptor antagonist
Products in this notice
Medicinal ingredients
- PEGVISOMANT 10 MG per VIAL
- PEGVISOMANT 15 MG per VIAL
- PEGVISOMANT 20 MG per VIAL